Dr. M Gallarate has the Chair of Pharmaceutical Technology and Legislation I and II the One Long Cycle Degree in Pharmacy and is teacher in the Post Graduate School in Hospital Pharmacy and in the Specialization Course in Ward-based Hospital Pharmacist of the Department of Scienza e Tecnologia del Farmaco of University of Torino. Her scientific activity concerns the advanced pharmaceutical technology for the development of colloidal systems such as microemulsions, emulsions, liposomes, lipid micro- and nanoparticles as possible drug delivery systems. At present, her research is focused to the formulation and characterization of solid lipid nanoparticles (SLN): new SLN production techniques were developed, as solvent dilution from O/W and W/O/W emulsions and from O/W microemulsions, and fatty acid coacervation. Several model drugs were entrapped in SLN and their over-time stability as well as their in vitro release from SLN was investigated. Recently, the experimental work has been focused on the possibility to vehicle lipophilic and hydrophilic anticancer in SLN and to evaluate their in vitro cytotoxicity towards specific cell lines and their biodistribution after administration to animals. A further research line involves the development of innovative nanosystems for drug intravitreal administration in the therapy of age-related eye pathology. She took part as component of Operative Unit and Principal Investigator to several financed projects concerning the development of nanosystems for drug delivery. She is author or co-author of almost 100 research papers on international journals, one Italian patent and of many congress communications.